Changeflow GovPing Pharma & Drug Safety Biodegradable Microcapsules and Method for Thei...
Routine Notice Added Final

Biodegradable Microcapsules and Method for Their Preparation

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published patent application US20260096991A1 for biodegradable microcapsules and methods for their preparation. The application relates to microcapsule compositions for drug delivery, classified under A61K. Filing date was September 7, 2023, with nine listed inventors.

What changed

The USPTO published patent application US20260096991A1 for biodegradable microcapsules and methods for their preparation. The patent relates to microcapsule compositions for drug delivery applications.

Affected parties including pharmaceutical manufacturers, drug delivery companies, and researchers should review the patent claims to assess potential licensing needs or design-around considerations for competing products.

What to do next

  1. Monitor for patent issuance
  2. Review patent claims for infringement

Archived snapshot

Apr 13, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION

Application US20260096991A1 Kind: A1 Apr 09, 2026

Inventors

Lynette Anne Makins HOLLAND, Marc RODRIGUEZ GARCIA, Nigel Patrick SOMERVILLE ROBERTS, Polly Helena Ruth KEEN, James Ward TAYLOR, Juliette Marie Caroline DELARUE, Phoebe Jane WILLIAMS, Huafu WANG, Scott Edward STEVENS

Abstract

The present invention relates to a method for preparing a microcapsule and to a method for preparing a microcapsule composition. The present invention also relates to the microcapsule and the microcapsule composition per se. The present invention also relates to uses of the microcapsules and to methods involving the microcapsule, including to prepare a formulated product. The present invention also relates to the formulated product per se.

CPC Classifications

A61K 9/1658 A61K 9/0095 A61K 9/1617 A61K 9/5015 A61K 9/5052 A61K 31/592

Filing Date

2023-09-07

Application No.

19115705

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260096991A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing Drug delivery systems
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!